TLSI
TriSalus Life Sciences, Inc.
Medical Devices · Healthcare · United States
3.70
close · 2026-10-30
value
7
cheaper than peers7
quality
2
stronger fundamentals2
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, latest year | -8.3% | 38 |
| cash flow yield, 3 years ago | -14.5% | 37 |
| earnings yield, 1 year ago | -35.4% | 30 |
| price to sales | 5.08× | 27 |
| cash flow yield, 1 year ago | -18.1% | 26 |
| cash flow yield, 2 years ago | -22.5% | 23 |
| earnings yield, latest year | -49.7% | 18 |
| earnings yield, 2 years ago | -181.9% | 7 |
| price to book | 34.58× | 5 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | -2.9% | 15 |
| operating margin | -94.5% | 14 |
| debt to equity | 269.3% | 13 |
3 of 4 measures available
Facts
| market cap | $228M |
| free cash flow | -$9.3M |
| employees | 102 |
| first trade | 2021-02-08 |
| next earnings | 2026-11-10 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.84 | -1.31 | -6.73 | -161.55 |
| free cash flow | -$18.9M | -$41.2M | -$51.2M | -$33.1M |
| net income | -$39.2M | -$30.0M | -$59.4M | -$47.2M |
| revenue | $45.2M | $29.4M | $18.5M | $12.4M |
| unusual items | -$6.8M | $9.1M | $958,000 | -$2.2M |